252 related articles for article (PubMed ID: 32766576)
1. Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction.
Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
bioRxiv; 2020 Jul; ():. PubMed ID: 32766576
[TBL] [Abstract][Full Text] [Related]
2. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
4. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
5. Biophysical investigation of interactions between SARS-CoV-2 spike protein and neuropilin-1.
Hou D; Cao W; Kim S; Cui X; Ziarnik M; Im W; Zhang XF
Protein Sci; 2023 Oct; 32(10):e4773. PubMed ID: 37656811
[TBL] [Abstract][Full Text] [Related]
6. Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
bioRxiv; 2021 Jul; ():. PubMed ID: 34341794
[TBL] [Abstract][Full Text] [Related]
7. Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2.
Peng C; Zhu Z; Shi Y; Wang X; Mu K; Yang Y; Zhang X; Xu Z; Zhu W
J Phys Chem Lett; 2020 Dec; 11(24):10482-10488. PubMed ID: 33274945
[TBL] [Abstract][Full Text] [Related]
8. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.
Chen RH; Yang LJ; Hamdoun S; Chung SK; Lam CW; Zhang KX; Guo X; Xia C; Law BYK; Wong VKW
Front Pharmacol; 2021; 12():634176. PubMed ID: 33897423
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction.
Xiong J; Xiang Y; Huang Z; Liu X; Wang M; Ge G; Chen H; Xu J; Zheng M; Chen L
Front Chem; 2021; 9():740702. PubMed ID: 34646813
[TBL] [Abstract][Full Text] [Related]
11. A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2).
Coghi P; Yang LJ; Ng JPL; Haynes RK; Memo M; Gianoncelli A; Wong VKW; Ribaudo G
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681178
[TBL] [Abstract][Full Text] [Related]
12. Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics.
Basit A; Karim AM; Asif M; Ali T; Lee JH; Jeon JH; Rehman SU; Lee SH
Front Pharmacol; 2021; 12():731828. PubMed ID: 34512357
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor.
Ahsan T; Sajib AA
Biochem Biophys Rep; 2021 Jul; 26():100982. PubMed ID: 33817352
[TBL] [Abstract][Full Text] [Related]
14. Binding of Human ACE2 and RBD of Omicron Enhanced by Unique Interaction Patterns Among SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Ziarnik M; Cao Y; Zhang XF; Im W
bioRxiv; 2022 Jan; ():. PubMed ID: 35118473
[TBL] [Abstract][Full Text] [Related]
15. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.
Xu C; Wang Y; Liu C; Zhang C; Han W; Hong X; Wang Y; Hong Q; Wang S; Zhao Q; Wang Y; Yang Y; Chen K; Zheng W; Kong L; Wang F; Zuo Q; Huang Z; Cong Y
Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33277323
[TBL] [Abstract][Full Text] [Related]
16. Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor.
Giordano D; De Masi L; Argenio MA; Facchiano A
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440241
[TBL] [Abstract][Full Text] [Related]
17. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.
Lu J; Sun PD
bioRxiv; 2020 Jul; ():. PubMed ID: 32637947
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.
Calcagnile M; Forgez P; Iannelli A; Bucci C; Alifano M; Alifano P
Biochimie; 2021 Jan; 180():143-148. PubMed ID: 33181224
[TBL] [Abstract][Full Text] [Related]
19. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
F1000Res; 2020; 9():576. PubMed ID: 32802318
[No Abstract] [Full Text] [Related]
20. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
